Th17 cells’ prevalence was accumulated in peripheral blood, tumors, and drain lymph nodes of HNSCC patients that may promote tumor growth by inducing angiogenesis (via IL-17) and exerting themselves immunosuppressive functions (41–43). The gene discussed is IL17A; the disease is neoplasm.